Primary Peritoneal High Grade Serous Adenocarcinoma

Explore clinical trials studying Primary Peritoneal High Grade Serous Adenocarcinoma. Study availability and eligibility vary by location and protocol.

12 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Primary Peritoneal High Grade Serous Adenocarcinoma trial results

Active, Not Recruiting

Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery

NCT03943173

Conditions: Adnexal Diseases, BRCA-Mutated Ovarian Carcinoma, BRCA1 Gene Mutation, +45 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer

NCT05276973

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +32 more
Locations: UCSF Medical Center-Mission Bay San Francisco, California, United States

Augusta University Medical Center Augusta, Georgia, United States

Cleveland Clinic Foundation Cleveland, Ohio, United States

University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States

View Trial Details

Primary Peritoneal High Grade Serous Adenocarcinoma

Primary Peritoneal High Grade Serous Adenocarcinoma trial results

Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery

Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer

Related conditions